- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Interplay between conformational selection and zymogen activation ; volume:8 ; number:1 ; day:6 ; month:3 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (6.3.2018), 1-10, 12.2018
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Chakraborty, Pradipta
- Beteiligte Personen und Organisationen
-
Acquasaliente, Laura
Pelc, Leslie A.
Di Cera, Enrico
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-21728-9
- URN
-
urn:nbn:de:1111-201805033727
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chakraborty, Pradipta
- Acquasaliente, Laura
- Pelc, Leslie A.
- Di Cera, Enrico
- SpringerLink (Online service)
Ähnliche Objekte (12)
Molecular basis of collybistin conformational activation
Small Molecules Attenuate the Interplay between Conformational Fluctuations, Early Oligomerization and Amyloidosis of Alpha Synuclein
Conformational changes involved in sGC activation
Conformational equilibria and intrinsic affinities define integrin activation
Protein dynamics and conformational selection in bidirectional signal transduction
Defining a conformational ensemble that directs activation of PPARγ
R-loop formation and conformational activation mechanisms of Cas9
Catenane organocatalyst breaks the linear scaling limitation through conformational selection
Conformational Selection in Enzyme‐Catalyzed Depolymerization of Bio‐based Polyesters
Conformational alteration in glycan induces phospholipase Cβ1 activation and angiogenesis
Inflammasome activation controlled by the interplay between post-translational modifications: emerging drug target opportunities
Interplay of structural preorganization and conformational sampling in UDP-glucuronic acid 4-epimerase catalysis
Molecular basis of collybistin conformational activation
Small Molecules Attenuate the Interplay between Conformational Fluctuations, Early Oligomerization and Amyloidosis of Alpha Synuclein
Conformational changes involved in sGC activation
Conformational equilibria and intrinsic affinities define integrin activation
Protein dynamics and conformational selection in bidirectional signal transduction
Defining a conformational ensemble that directs activation of PPARγ
R-loop formation and conformational activation mechanisms of Cas9
Catenane organocatalyst breaks the linear scaling limitation through conformational selection
Conformational Selection in Enzyme‐Catalyzed Depolymerization of Bio‐based Polyesters
Conformational alteration in glycan induces phospholipase Cβ1 activation and angiogenesis
Inflammasome activation controlled by the interplay between post-translational modifications: emerging drug target opportunities
Interplay of structural preorganization and conformational sampling in UDP-glucuronic acid 4-epimerase catalysis
Molecular basis of collybistin conformational activation
Small Molecules Attenuate the Interplay between Conformational Fluctuations, Early Oligomerization and Amyloidosis of Alpha Synuclein
Conformational changes involved in sGC activation
Conformational equilibria and intrinsic affinities define integrin activation
Protein dynamics and conformational selection in bidirectional signal transduction
Defining a conformational ensemble that directs activation of PPARγ
R-loop formation and conformational activation mechanisms of Cas9
Catenane organocatalyst breaks the linear scaling limitation through conformational selection
Conformational Selection in Enzyme‐Catalyzed Depolymerization of Bio‐based Polyesters
Conformational alteration in glycan induces phospholipase Cβ1 activation and angiogenesis
Inflammasome activation controlled by the interplay between post-translational modifications: emerging drug target opportunities